文献速递其他结缔组织病血管炎

直接抗病毒药物时代后冷球蛋白血症的疾病谱变迁

Cryoglobulinemia after the era of chronic hepatitis C infection.
PubMed 文献 · Semin Arthritis Rheum · 2020-05-26

法国单中心纵向队列研究纳入679例持续性混合型冷球蛋白血症患者,比较DAA时代前后冷球蛋白血症病因构成与发病率变化。结果显示2011-2014年与2015-2018年新发病例数分别为395例和284例,病因首位由慢性HCV感染转为自身免疫病(SLE 28.9%、干燥综合征10.7%),HCV相关与非HCV相关冷球蛋白血症性血管炎发病率相似。

要点

  • DAA时代后混合型冷球蛋白血症病因首位由慢性HCV感染转为自身免疫病。
  • 2011-2014年与2015-2018年新发混合型冷球蛋白血症分别为395例与284例。
  • HCV相关与非HCV相关冷球蛋白血症性血管炎发病率相似。

核心结论

  • 直接抗病毒药物已显著改变混合型冷球蛋白血症的疾病谱与发病率。

主要发现

  • 679例中位年龄55.5岁、女性54.5%、慢性HCV感染381例(56.1%)。
  • 373例(54.9%)为II型、306例(45.1%)为III型冷球蛋白,139例(21.5%)有冷球蛋白血症性血管炎。
  • 2011-2014年与2015-2018年新发混合型冷球蛋白血症分别为395例与284例。
  • 2011年慢性HCV感染占所有混合型冷球蛋白血症的62.5%,目前自身免疫病为主要病因,其中SLE占28.9%、干燥综合征占10.7%。
  • HCV相关与非HCV相关混合型冷球蛋白血症的冷球蛋白血症性血管炎发病率相似。

临床怎么用

  • 在DAA时代评估混合型冷球蛋白血症时,应将自身免疫病尤其是SLE和干燥综合征列为主要病因进行筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Historically chronic hepatitis C virus (HCV) infection accounted for the majority of mixed cryoglobulinemia (MC). The advent of direct-acting antivirals (DAA) against HCV has dramatically changed the management and the prevalence of chronic HCV infection. We aimed to describe the spectrum of MC in the era of DAA agents. METHODS: We performed a longitudinal cohort study between 2011 and 2018 from a single-center French university hospital's database of 15 970 patients screened for MC. Epidemiological, clinical and immunological data of MC were recorded. We evaluated the incidence and evolution of MC before and after the era of DAA agents and compared HCV and non-HCV related MC. RESULTS: Among 742 patients who tested positive for cryoglobulin, 679 [mean age 55.5 years, 54.5% female and 381 (56.1%) with chronic HCV infection] patients with persistent MC were included in the study. 373 (54.9%) had type II and 306 (45.1%) type III cryoglobulin, and 139 (21.5%) had cryoglobulinemia vasculitis (CryoVas). The incidence of MC decreased steadily with 395 and 284 incident cases during 2011-2014 and 2015-2018, respectively. In 2011, the leading cause was chronic HCV infection (62.5% of all MC). Currently, autoimmune diseases [systemic lupus erythematosus (28.9%) and Sjögren's syndrome (10.7%)] are the main cause of MC. The incidence of CryoVas was similar between HCV-and non HCV-related MC. CONCLUSION: Direct-acting antivirals have dramatically changed the landscape and the incidence of MC.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Boleto G, Ghillani-Dalbin P, Musset L, et al. Cryoglobulinemia after the era of chronic hepatitis C infection. Semin Arthritis Rheum. 2020. PMID: 32521323. doi:10.1016/j.semarthrit.2020.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。